Alterola Biotech, Inc. develops medical cannabis products. The company is headquartered in Birkenhead, Merseyside and currently employs 1 full-time employees. The company went IPO on 2010-03-09. The firm is developing cannabinoid, cannabinoid-like, and non-cannabinoid pharmaceutical active pharmaceutical ingredients (APIs). The firm has three areas of focus: development of regulated pharmaceuticals (human and animal health) and regulated food products; production of APIs and food-grade ingredients; and formulation, and drug delivery, providing bioavailability, solubility, and stability. The company also focuses on developing new medicines from various sources, including botanical, traditional chemical synthesis, and biosynthetic methodologies. Its subsidiaries include ABTI Pharma Limited, Phytotherapeutix Ltd, and Ferven Ltd.

ABTI Profile, Market Tickers and Other

ABTI profile